News

Why Is Minerva Surgical (UTRS) Stock Down 50% Today?

Minerva Surgical (NASDAQ: UTRS ) stock is taking a beating on Monday after the women's healthcare company announced that its shares will be delisted later this month. According to a filing with the Securities and Exchange Commission (SEC), the company's shares will no longer trade on the Nasdaq Exchange starting on Dec. 29.

12/18/2023

Minerva Surgical Reports Third Quarter 2023 Financial Results

SANTA CLARA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, today reported third quarter financial results for the period ended September 30, 2023.

11/13/2023

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Minerva Surgical, Inc. (UTRS) a buy, sell, or hold?

Minerva Surgical, Inc. (UTRS) can sell. Click on Rating Page for detail.

What is Minerva Surgical, Inc.'s stock price?

The price of Minerva Surgical, Inc. (UTRS) is 0.0001 and it was updated on 2025-05-09 01:21:20.

Is Minerva Surgical, Inc. (UTRS) overvalued or undervalued?

Currently Minerva Surgical, Inc. (UTRS) is in undervalued.

News

From:

To:

News
Minerva Surgical, Inc. (UTRS) Q2 2023 Earnings Call Transcript Minerva Surgical, Inc. (NASDAQ:UTRS ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Caroline Corner - IR Todd Usen - President & CEO Joel Jung - CFO Conference Call Participants Operator Greetings, and welcome to the Minerva Surgical Q2 2023 Earnings Call. At this time all participants are in listen-only mode. Mon, Aug. 07, 2023
Minerva Surgical, Inc. (UTRS) Reports Q2 Loss, Misses Revenue Estimates Minerva Surgical, Inc. (UTRS) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.20 per share a year ago. Wed, Aug. 02, 2023
Minerva Surgical Reports Second Quarter 2023 Financial Results SANTA CLARA, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, today reported second quarter financial results for the period ended June 30, 2023. Wed, Aug. 02, 2023
The Main Differences Between Penny Stocks and Blue Chips Penny stocks and blue-chip stocks represent two distinct categories of equities that cater to different types of investors with varying risk appetites and investment goals. Understanding the fundamental differences between these two types of stocks is crucial for investors to make informed decisions and align their investment strategies with their financial objectives. Sat, Jun. 03, 2023
Best Penny Stocks Today? 3 Under $1 To Watch Now If you're looking for the best penny stocks to buy today, you should be well-prepared to deal with high volatility. Whether it's the latest debt ceiling crisis, pandemic fear reemerging, today's Fed meeting minutes from May, or speeches by Janet Yellen and Federal Reserve members, there are plenty of headlines to contend with. Wed, May. 24, 2023

Transcripts

Transcipts Data
Minerva Surgical, Inc. (UTRS) on Q2 2023 Results - Earnings Call Transcript SA Transcripts Mon, Aug. 07, 2023
Minerva Surgical, Inc. (UTRS) on Q1 2023 Results - Earnings Call Transcript SA Transcripts Tue, May. 02, 2023
Minerva Surgical, Inc. (UTRS) on Q4 2022 Results - Earnings Call Transcript SA Transcripts Tue, Mar. 21, 2023
Minerva Surgical, Inc. (UTRS) on Q3 2022 Results - Earnings Call Transcript SA Transcripts Mon, Nov. 14, 2022
Minerva Surgical, Inc. (UTRS) on Q2 2022 Results - Earnings Call Transcript SA Transcripts Sat, Aug. 13, 2022
Minerva Surgical, Inc. (UTRS) on Q1 2022 Results - Earnings Call Transcript SA Transcripts Sun, May. 15, 2022

SEC Filings

SEC Filings
Minerva Surgical, Inc. (UTRS) - 15-12G SEC Filings 01/04/2024
Minerva Surgical, Inc. (UTRS) - S-8 POS SEC Filings 12/26/2023
Minerva Surgical, Inc. (UTRS) - 25 SEC Filings 12/26/2023
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 12/15/2023
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 11/13/2023
Minerva Surgical, Inc. (UTRS) - 10-Q - Quarterly Report SEC Filings 11/13/2023
Minerva Surgical, Inc. (UTRS) - SC 13E3/A SEC Filings 11/02/2023
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 11/02/2023
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 10/13/2023
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 09/29/2023
Minerva Surgical, Inc. (UTRS) - SC 13E3 SEC Filings 09/28/2023
Minerva Surgical, Inc. (UTRS) - SC 13D/A SEC Filings 09/28/2023
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 09/28/2023
Minerva Surgical, Inc. (UTRS) - 10-Q - Quarterly Report SEC Filings 08/03/2023
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 08/02/2023
Minerva Surgical, Inc. (UTRS) - SC 13D/A SEC Filings 07/07/2023
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 07/07/2023
Minerva Surgical, Inc. (UTRS) - SC 13D/A SEC Filings 07/06/2023
Minerva Surgical, Inc. (UTRS) - SC 13G/A SEC Filings 05/10/2023
Minerva Surgical, Inc. (UTRS) - 10-Q - Quarterly Report SEC Filings 05/03/2023
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 05/02/2023
Minerva Surgical, Inc. (UTRS) - 10-K/A - Current report SEC Filings 05/01/2023
Minerva Surgical, Inc. (UTRS) - 10-K - Current report SEC Filings 03/22/2023
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 03/21/2023
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 03/14/2023
Minerva Surgical, Inc. (UTRS) - 3 SEC Filings 03/14/2023
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 03/07/2023
Minerva Surgical, Inc. (UTRS) - SC 13D/A SEC Filings 02/21/2023
Minerva Surgical, Inc. (UTRS) - SC 13G SEC Filings 02/14/2023
Minerva Surgical, Inc. (UTRS) - SC 13G/A SEC Filings 02/10/2023
Minerva Surgical, Inc. (UTRS) - 4 SEC Filings 02/10/2023
Minerva Surgical, Inc. (UTRS) - SC 13D SEC Filings 02/09/2023
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 02/09/2023
Minerva Surgical, Inc. (UTRS) - 3 SEC Filings 02/09/2023
Minerva Surgical, Inc. (UTRS) - 3 SEC Filings 02/08/2023
Minerva Surgical, Inc. (UTRS) - SC 13D/A SEC Filings 01/24/2023
Minerva Surgical, Inc. (UTRS) - DEF 14A SEC Filings 01/23/2023
Minerva Surgical, Inc. (UTRS) - DEFA14A SEC Filings 01/17/2023
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 01/17/2023
Minerva Surgical, Inc. (UTRS) - PRE 14A SEC Filings 01/13/2023
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 12/30/2022
Minerva Surgical, Inc. (UTRS) - DEFA14A SEC Filings 12/28/2022
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 12/28/2022
Minerva Surgical, Inc. (UTRS) - 8-K/A - Current report SEC Filings 11/16/2022
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 11/14/2022
Minerva Surgical, Inc. (UTRS) - 10-Q - Quarterly Report SEC Filings 11/14/2022
Minerva Surgical, Inc. (UTRS) - SC 13G/A SEC Filings 11/03/2022
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 11/02/2022
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 08/09/2022
Minerva Surgical, Inc. (UTRS) - 4 SEC Filings 08/09/2022
Minerva Surgical, Inc. (UTRS) - 10-Q - Quarterly Report SEC Filings 08/09/2022
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 08/03/2022
Minerva Surgical, Inc. (UTRS) - 3 SEC Filings 07/28/2022
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 07/21/2022
Minerva Surgical, Inc. (UTRS) - 4 SEC Filings 06/14/2022
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 06/13/2022
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 06/10/2022
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 05/11/2022
Minerva Surgical, Inc. (UTRS) - 10-Q - Quarterly Report SEC Filings 05/11/2022
Minerva Surgical, Inc. (UTRS) - DEFA14A SEC Filings 04/22/2022
Minerva Surgical, Inc. (UTRS) - DEF 14A SEC Filings 04/22/2022
Minerva Surgical, Inc. (UTRS) - 10-K - Current report SEC Filings 03/23/2022
Minerva Surgical, Inc. (UTRS) - 8-K/A - Current report SEC Filings 03/22/2022
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 03/08/2022
Minerva Surgical, Inc. (UTRS) - SC 13G SEC Filings 02/11/2022
Minerva Surgical, Inc. (UTRS) - SC 13G SEC Filings 02/10/2022
Minerva Surgical, Inc. (UTRS) - 4/A SEC Filings 02/10/2022
Minerva Surgical, Inc. (UTRS) - 3/A SEC Filings 02/10/2022
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 01/31/2022
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 01/13/2022
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 01/12/2022
Minerva Surgical, Inc. (UTRS) - 4 SEC Filings 12/17/2021
Minerva Surgical, Inc. (UTRS) - 4 SEC Filings 12/15/2021
Minerva Surgical, Inc. (UTRS) - 4/A SEC Filings 12/08/2021
Minerva Surgical, Inc. (UTRS) - 3/A SEC Filings 12/08/2021
Minerva Surgical, Inc. (UTRS) - 8-K - Current report SEC Filings 12/02/2021
Minerva Surgical, Inc. (UTRS) - 10-Q - Quarterly Report SEC Filings 12/02/2021
Minerva Surgical, Inc. (UTRS) - SC 13D SEC Filings 11/17/2021
Minerva Surgical, Inc. (UTRS) - SC 13G SEC Filings 11/01/2021
Minerva Surgical, Inc. (UTRS) - 4 SEC Filings 10/28/2021
Minerva Surgical, Inc. (UTRS) - SC 13G SEC Filings 10/27/2021
Minerva Surgical, Inc. (UTRS) - 4 SEC Filings 10/27/2021
Minerva Surgical, Inc. (UTRS) - S-8 SEC Filings 10/25/2021
Minerva Surgical, Inc. (UTRS) - 424B4 SEC Filings 10/25/2021
Minerva Surgical, Inc. (UTRS) - EFFECT SEC Filings 10/22/2021
Minerva Surgical, Inc. (UTRS) - EFFECT SEC Filings 10/22/2021
Minerva Surgical, Inc. (UTRS) - SEC STAFF LETTER SEC Filings 10/21/2021
Minerva Surgical, Inc. (UTRS) - 3 SEC Filings 10/21/2021
Minerva Surgical, Inc. (UTRS) - CORRESP SEC Filings 10/19/2021
Minerva Surgical, Inc. (UTRS) - CERT SEC Filings 10/19/2021
Minerva Surgical, Inc. (UTRS) - SEC STAFF LETTER SEC Filings 10/15/2021
Minerva Surgical, Inc. (UTRS) - S-1/A SEC Filings 10/15/2021
Minerva Surgical, Inc. (UTRS) - 8-A12B SEC Filings 10/15/2021
Minerva Surgical, Inc. (UTRS) - CORRESP SEC Filings 10/07/2021
Minerva Surgical, Inc. (UTRS) - S-1 SEC Filings 09/27/2021
Minerva Surgical, Inc. (UTRS) - SEC STAFF LETTER SEC Filings 09/24/2021
Minerva Surgical, Inc. (UTRS) - DRSLTR SEC Filings 09/08/2021
Minerva Surgical, Inc. (UTRS) - DRS/A SEC Filings 09/08/2021
Minerva Surgical, Inc. (UTRS) - UPLOAD SEC Filings 08/18/2021
Minerva Surgical, Inc. (UTRS) - DRS SEC Filings 07/23/2021
Minerva Surgical, Inc. (UTRS) - D SEC Filings 05/26/2020
Minerva Surgical, Inc. (UTRS) - D SEC Filings 12/04/2019
Minerva Surgical, Inc. (UTRS) - D SEC Filings 05/16/2019
Minerva Surgical, Inc. (UTRS) - D SEC Filings 01/04/2019
Minerva Surgical, Inc. (UTRS) - D SEC Filings 03/13/2018
Minerva Surgical, Inc. (UTRS) - D SEC Filings 12/27/2016
Minerva Surgical, Inc. (UTRS) - D SEC Filings 01/08/2016
Minerva Surgical, Inc. (UTRS) - D SEC Filings 09/22/2014
Minerva Surgical, Inc. (UTRS) - D SEC Filings 12/21/2012
Minerva Surgical, Inc. (UTRS) - D SEC Filings 06/02/2011
Minerva Surgical, Inc. (UTRS) - D SEC Filings 03/15/2011
Minerva Surgical, Inc. (UTRS) - D SEC Filings 11/22/2010
Minerva Surgical, Inc. (UTRS) - D SEC Filings 02/24/2010
Minerva Surgical, Inc. (UTRS) - D SEC Filings 01/26/2010
Minerva Surgical, Inc. (UTRS) - REGDEX SEC Filings 12/19/2008

Press Releases

StockPrice Release
Minerva surgical reports third quarter 2023 financial results 11/13/2023
Minerva surgical reports second quarter 2023 financial results 08/02/2023
Minerva surgical to announce first quarter 2023 financial results 04/18/2023
Minerva surgical announces the appointment of kaile zagger as chief commercial officer 03/21/2023
Minerva surgical reports fourth quarter and full-year 2022 financial results 03/21/2023
Minerva surgical to announce fourth quarter and full year 2022 financial results 03/08/2023
Minerva surgical closes $30 million private placement of common stock 02/09/2023
Minerva surgical to present at the 41st annual j.p. morgan healthcare conference 01/03/2023
Minerva surgical announces retirement of ceo david clapper and appointment of todd usen as company president and ceo 12/28/2022
Minerva surgical announces $30 million private placement of common stock led by accelmed partners 12/27/2022
Minerva surgical to present at the 34th annual piper sandler healthcare conference 11/21/2022
Minerva surgical announces change of date for third quarter 2022 earnings release and conference call 11/07/2022
Minerva surgical to announce third quarter 2022 financial results 10/26/2022
Minerva surgical to present at the h.c. wainwright 24th annual global investment conference 08/29/2022
Minerva surgical announces time to talk campaign 08/03/2022
Minerva surgical to announce second quarter 2022 financial results 07/28/2022
Minerva surgical announces appointment of derrick sung, ph.d. to board of directors 07/21/2022
Minerva surgical to present at upcoming investor conferences 05/10/2022
Minerva surgical to announce fourth quarter and full-year financial results 02/22/2022
Minerva surgical to present at the 11th annual svb leerink global healthcare conference 01/31/2022
Minerva surgical reports preliminary fourth quarter and full year 2021 revenue 01/11/2022
Minerva surgical to present at the 40th annual j.p. morgan healthcare conference 01/04/2022
Minerva surgical, inc. third quarter 2021 financial results 12/02/2021
Minerva surgical to participate in the 33rd annual piper sandler virtual healthcare conference 11/18/2021
Minerva surgical launches educational website for women living with abnormal uterine bleeding 11/17/2021
Minerva surgical announces closing of initial public offering 10/26/2021
Minerva surgical announces pricing of initial public offering 10/21/2021

More Headlines

News
Why Is Minerva Surgical (UTRS) Stock Up 229% Today? Minerva Surgical (NASDAQ: UTRS ) stock is rising higher on Wednesday despite a lack of news from the surgical and medical instrument manufacturing company. There have been no new press releases or filings with the Securities and Exchange Commission (SEC) that would explain why shares of UTRS stock are rising today. 05/24/2023
Minerva Surgical, Inc. (UTRS) Q1 2023 Earnings Call Transcript Minerva Surgical, Inc. (NASDAQ:UTRS ) Q1 2023 Earnings Conference Call May 2, 2023 4:30 PM ET Company Participants Caroline Corner - Investor Relations Todd Usen - President & CEO, Director Joel Jung - Chief Financial Officer Conference Call Participants Phillip Dantoin - Piper Sandler Operator Good day and thank you for standing by. Welcome to Minerva Surgical First Quarter 2023 Earnings Conference Call. 05/02/2023
Minerva Surgical to Announce First Quarter 2023 Financial Results SANTA CLARA, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a medical technology company focused on solutions to meet the distinct uterine healthcare needs of women, announced today that it will release its first quarter 2023 financial results on Tuesday, May 2, 2023. In conjunction with the release, the company will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. 04/18/2023
Minerva Surgical, Inc. (UTRS) Q4 2022 Earnings Call Transcript Minerva Surgical, Inc. (NASDAQ:UTRS ) Q4 2022 Earnings Conference Call March 21, 2023 4:30 PM ET Company Participants Caroline Corner - IR Todd Usen - President and CEO Joel Jung - CFO Conference Call Participants Operator Thank you for standing by, and welcome to Minerva's Fourth Quarter and Full Year 2022 Earnings Call. At this time, all participants are in a listen-only mode. 03/21/2023
Minerva Surgical to Announce Fourth Quarter and Full Year 2022 Financial Results SANTA CLARA, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it will release its fourth quarter and full year 2022 financial results on Tuesday, March 21, 2023. In conjunction with the release, the company will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. 03/08/2023
Minerva Surgical to Present at the 41st Annual J.P. Morgan Healthcare Conference SANTA CLARA, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management team will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12th at 9:45 a.m. Pacific Time. 01/03/2023
Minerva Surgical to Present at the 34th Annual Piper Sandler Healthcare Conference SANTA CLARA, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the 34th Annual Piper Sandler Healthcare Conference on Wednesday, November 30, 2022 at 11:00 a.m. Eastern Time in New York City, NY. 11/21/2022
Minerva Surgical, Inc. (UTRS) Q3 2022 Earnings Call Transcript Minerva Surgical, Inc. (NASDAQ:UTRS ) Q3 2021 Earning Conference Call November 14, 2022 4:30 PM ET Company Representatives Dave Clapper - President, Chief Executive Officer Joel Jung - Chief Financial Officer Caroline Corner - Investor Relations Conference Call Participants Rohan Raheja - J.P. Morgan Matt O'Brien - Piper Sandler Operator Good day, and welcome to Minerva's Third Quarter 2022 Earnings Call. 11/14/2022
Minerva Surgical Announces Change of Date for Third Quarter 2022 Earnings Release and Conference Call SANTA CLARA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it has changed the date of its previously announced earnings conference call. It will now report its third quarter 2022 financial results on Monday, November 14, 2022. In conjunction with the release, the company will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. 11/07/2022
Minerva Surgical to Announce Third Quarter 2022 Financial Results SANTA CLARA, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it will release its third quarter 2022 financial results on Wednesday, November 9, 2022. In conjunction with the release, the company will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. 10/26/2022
Minerva Surgical to Present at the H.C. Wainwright 24th Annual Global Investment Conference SANTA CLARA, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the H.C. Wainwright 24th Annual Global Investment Conference. The presentation will be available on-demand for registered participants through the H.C. Wainwright conference portal starting at 7:00 a.m. Eastern Time on Monday, September 12, 2022. 08/29/2022
Minerva Surgical, Inc. (UTRS) CEO Dave Clapper on Q2 2022 Results - Earnings Call Transcript Minerva Surgical, Inc. (NASDAQ:UTRS ) Q2 2022 Results Conference Call August 9, 2022 4:30 PM ET Company Participants Caroline Corner - Investor Relations Dave Clapper - President and Chief Executive Officer Joel Jung - Chief Financial Officer Conference Call Participants Rohin Patel - JPMorgan Matthew O'Brien - Piper Sandler Operator Good day and thank you for standing by. Welcome to the Minerva Surgical Second Quarter 2022 Earnings Call. 08/13/2022
Minerva Surgical to Announce Second Quarter 2022 Financial Results SANTA CLARA, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it will release its second quarter 2022 financial results on Tuesday, August 9, 2022. In conjunction with the release, the company will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. 07/28/2022
Minerva Surgical, Inc. (UTRS) CEO David Clapper on Q1 2022 Results - Earnings Call Transcript Minerva Surgical, Inc. (NASDAQ:UTRS ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Caroline Corner - Investor Relations David Clapper - President and Chief Executive Officer Joel Jung - Chief Financial Officer Conference Call Participants Danielle Antalffy - SVB Securities Operator Good day, and thank you for standing by. Welcome to the Minerva Surgical First Quarter 2022 Earnings Call. 05/15/2022
Minerva Surgical to Present at Upcoming Investor Conferences SANTA CLARA, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the following investor conferences: 05/10/2022
Minerva Surgical to Announce Fourth Quarter and Full-Year Financial Results SANTA CLARA, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it will release its fourth quarter and full-year 2021 financial results on Tuesday, March 8, 2022. In conjunction with the release, the company will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. 02/22/2022
Minerva Surgical to Present at the 11th Annual SVB Leerink Global Healthcare Conference SANTA CLARA, Calif., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the 11th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 16, 2022 at 3:40 p.m. Eastern Time. 01/31/2022
Minerva Surgical's Preliminary FY21 Revenues Top Expectations Medical device company Minerva Surgical Inc (NASDAQ: UTRS) expects Q4 FY21 sales of $13.5 million - $13.7 million, versus $13.6 million posted a year ago and the consensus of $13.45 million. FY21 sales are expected to be $52.0 million - $52.2 million (prior view $51.0 million - $52.0 million), compared to $37.8 million in FY20 and the consensus of $51.75 million. 01/12/2022
Minerva Surgical to Present at the 40th Annual J.P. Morgan Healthcare Conference SANTA CLARA, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 11:15 a.m. Eastern Time. 01/04/2022
Minerva Surgical - Uterine Play For Sale Minerva Surgical aims to transform uterine healthcare with its minimally invasive procedures. I like the potential of the business, and despite the current growth, I wonder if the competitive strength of the solutions is strong enough. 11/02/2021

Unlock

UTRS Ratings Summary

UTRS Quant Ranking